EHEba H. Hathout

Eba H. Hathout

*This is an algorithmically generated author record based on publicly available information.

Eba H. Hathout has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dynamic Production of Hypoxia-Inducible Factor-1α in Early Transplanted Islets

    by G. Miao, R. P. Ostrowski, J. Mace, J. Hough, A. Hopper, R. Peverini, R. Chinnock, J. Zhang, E. Hathout


  • Air pollution and type 1 diabetes in children

    by Eba H Hathout, W Lawrence Beeson, Mariam Ischander, Ravindra Rao, John W Mace

    Over the past decade, there has been a worldwide largely unexplained increase in the incidence of type 1 diabetes in young children. This study explores the quantitative role of exposure to specific air pollutants in the development of type 1 diabetes in children. A total of 402 children were retrospectively studied. Zip code-related, time-specific birth-to-diagnosis exposure to five ambient air pollutants was obtained for 102 children with type 1 diabetes and 300 healthy children receiving care at a single hospital. Pollution exposure levels were created by summing up zip code-specific pollution data and dividing by months of exposure from birth to diagnosis. Analysis employed chi2, two-tailed independent sample t-test and unconditional logistic regression. Odds ratio (OR) was significantly high for cumulative exposure to ambient ozone (O3) and sulfate (SO4) in cases compared with controls, OR = 2.89 [95% confidence interval (CI) = 1.80-4.62] and OR = 1.65 (CI = 1.20-2.28), respectively, even after adjustment for several potential confounders. Passive smoking was more frequent in children with diabetes (30 vs. 10%, p = 0.001). Attending day care and breast feeding in infancy were less frequent in children with diabetes (14 vs. 23%, p = 0.025; 59 vs. 78%, p = 0.001). Family history of diabetes, autoimmune disease and drug abuse was more frequent in cases (p < 0.01). Cumulative exposure to ozone and sulfate in ambient air may predispose to the development of type 1 diabetes in children. Early infant formula feeding and passive smoking in the household may precipitate or accelerate the onset of type 1 diabetes.


  • In Vitro and In Vivo Improvement of Islet Survival Following Treatment with Nerve Growth Factor

    by Gang Miao, John Mace, Michael Kirby, Andrew Hopper, Ricardo Peverini, Richard Chinnock, James Shapiro, Eba Hathout

    Background. Nerve growth factor (NGF) has been reported to play an important regulatory role in pancreatic beta-cell function. However, the usefulness of NGF in a transplantation setting is unknown. Methods. A marginal number of islet cells (260 islet equivalents/recipient) cultured for 24 hr with NGF (500 ng/ml) was syngeneically transplanted under the kidney capsule of streptozotocin-induced diabetic Balb/c mice. Fluorescence microscopy was used to evaluate islet viability. Islet function was evaluated in vitro and in vivo by static assay and glucose tolerance test, respectively. Results. In vitro, improved viability and survival were found in murine islets cultured in serum-free medium for 96 hr with 500 ng/ml NGF (PP<0.05), and 20 mmol/L glucose conditions. In vivo, 67% of recipients with a submarginal number of islets cultured in NGF attained normoglycemia for more than 120 days, whereas transplanted islets without NGF treatment survived a maximum of 13 days in control mice. At posttransplant day 4, recipients of NGF-cultured islets showed significant improvement of glucose tolerance. On immunohistochemistry, the kidney capsules containing NGF-cultured islets displayed higher insulin content, and more dilated neoplastic microvessels than control renal capsules. The number of apoptotic cells using TUNEL staining decreased by nearly 50% in NGF-cultured islet grafts in comparison to control islet grafts. Conclusions. The above data suggest potential advantages of NGF for islet survival following transplantation. This neurotrophic approach may prove beneficial in human islet transplantation.


  • Home Use of the GlucoWatch G2 Biographer in Children With Diabetes

    by Eba Hathout, Nina Patel, Christina Southern, Julie Hill, Reginald Anderson, Jeannine Sharkey, Merrilee Hadley-Scofield, Long Tran, Amy Leptien, Margarita Lopatin, et al.

    Objective. To evaluate usability, accuracy, and hypoglycemia detection of the GlucoWatch G2 Biographer (GW2B) in children aged 1 to 17 years.


  • Effect of Therapy with Insulin Glargine (Lantus ® ) on Glycemic Control in Toddlers, Children, and Adolescents with Diabetes

    by Eba H. Hathout, Leigh Fujishige, Jonathan Geach, Mariam Ischandar, Shinichiro Maruo, John W. Mace

    To determine the effect of insulin glargine on glycemic control in pediatric type 1 and 2 diabetes, a retrospective repeated-measure analysis of variance was performed of hemoglobin A1C (HbA1C), frequency of hypoglycemia and hyperglycemia, mean blood glucose, body mass index (BMI), and daily weight-adjusted insulin dosage before and after institution of glargine therapy in 72 children and adolescents with diabetes. At glargine start, age range was 1.2-19.6 years, mean age was 12.5 ± 4.6 years, BMI was 22.48 ± 6.3 kg/m2, and mean HbA1C was 9.7 ± 1.9%. Mean duration of diabetes was 3.58 years, and mean baseline insulin dose was 0.93 U/kg/day. Gender breakdown was 60% female, and the majority (83%) had type 1 diabetes. Average HbA1C decreased from 9.5% pre-glargine to 8.6% post-glargine (p < 0.001). HbA1C decrease was significant in both types of diabetes without a concomitant increase in frequency of hypoglycemia, BMI, or weight-adjusted insulin dose. Hypoglycemia decreased significantly in type 1 diabetes. Thus, glargine therapy may decrease HbA1C and frequency of hypoglycemia in toddlers, children, and adolescents with diabetes, without an increase in BMI or insulin requirements.


  • Open Access

    Pediatric Post‐Transplant Diabetes: Data From a Large Cohort of Pediatric Heart‐Transplant Recipients

    by Eba H. Hathout, Richard E. Chinnock, Joyce K. Johnston, James A. Fitts, Anees J. Razzouk, John W. Mace, Leonard L. Bailey

    A retrospective analysis of 381 pediatric heart‐transplant recipients was performed to determine the frequency, characteristics, and risk factors for post‐transplant diabetes. The rate of post‐trans...


  • Clinical, Autoimmune, and HLA Characteristics of Children Diagnosed With Type 1 Diabetes Before 5 Years of Age

    by Eba H. Hathout, Noelle Hartwick, Omar R. Fagoaga, Anna Rita Colacino, Jeannine Sharkey, Michael Racine, Sandra Nelsen-Cannarella, John W. Mace

    Background. Little is known about auxologic, autoimmune, and HLA characteristics specific to children with early-onset diabetes (EOD). HLA subtypes have been shown to play an important part in the determination of islet-cell autoimmunity and in the pace and intensity of the β-cell destructive process. Objectives. Our goals were to: 1) outline auxologic, autoimmune, and HLA class II characteristics of children diagnosed with type 1 diabetes before 5 years of age (EOD); 2) evaluate differences between EOD and later-onset or non-age-stratified type 1 diabetes; and 3) investigate the relation between type 1 diabetes-related HLA subtypes and markers of diabetic autoimmunity in EOD. Methods. Forty children with EOD were studied. Auxologic and antibody radioimmunoassay data were obtained by retrospective analysis of records. HLA diabetes-related class II alleles were typed by polymerase chain reaction using sequence-specific primers. Results. At diagnosis, the average age of the EOD study patients was 2.6 years, body mass index was 16.9 kg/m2, and weight was 106% of average weight for height. When compared with a matched subgroup of children with later-onset type 1 diabetes, preschoolers did not significantly differ in terms of birth weight or body mass index. The frequency of positive islet cell antibodies 512 and glutamic acid decarboxylase 65 antibodies was significantly less in EOD (28.6% and 31.6%, respectively). There were significant differences in the frequencies of some diabetes-related HLA alleles and haplotypes between the early-onset group and a large non-age-stratified type 1 diabetes group. None of the patients with EOD had either of the protective DRB1*1501 or DQB1*0602 alleles. There was a negative correlation between glutamic acid decarboxylase and the predisposing haplotype DR3/DQ2. Conclusions. Children diagnosed with type 1 diabetes before 5 years of age may have different diabetes-related autoimmune and genetic characteristics from those diagnosed at a later age.


  • Glycemic, Auxologic, and Seasonal Aspects of Continuous Subcutaneous Insulin Infusion Therapy in Children and Young Adults with Type 1 Diabetes

    by Eba H. Hathout, Travis McClintock, Jeannine Sharkey, Dennis Kytsenko, Noelle Hartwick, Merrilee Hadley-Scofield, Shurree Torgeson, John W. Mace

    Use of continuous subcutaneous insulin infusion (CSII) therapy has increased among patients with type 1 diabetes. This study was performed: (1) to evaluate the effect of CSII on diabetes control in children and young adults, (2) to detect effects of CSII on weight, body mass index (BMI), and insulin requirements, (3) to investigate seasonal variation in diabetes control during CSII therapy, and (4) to investigate the effect of season of initiation of CSII on glycemic control. Thirty-nine patients, ranging in age from 10.1 to 20.5 years, with type 1 diabetes were studied. Quarterly data over 12 months preceding and following CSII initiation were obtained retrospectively. Variables were compared over similar time periods. SAS was used for descriptive and paired t test analysis. (1) Mean blood glucose level was significantly lower at 3 months but not different from baseline at 6, 9, and 12 months post-CSII. (2) Glycosylated hemoglobin (HbA1c) was significantly lower at 3 and 6 months but not at 9 and 12 months post-CSII. (3) There was no significant difference in the frequency of hypoglycemia or hyperglycemia at any of the time periods studied. (4) There was an initial but unsustained decrease in daily weight-adjusted insulin requirements after CSII. (5) There was a rapid, sustained increase in weight and BMI following CSII in females. (6) Frequency of ketoacidosis decreased in two patients. (7) There was no seasonal variation in weight change, HbA1c, or frequency of measured hypoglycemic episodes with CSII. (8) There was some effect of the season of initiation of CSII therapy on glycemic control. Thus, (1) CSII glycemic benefits may not be sustained, (2) weight gain is a significant effect of CSII in adolescent females, and (3) CSII may be a means of decreasing ketoacidosis episodes, and eliminating seasonal variability in diabetes control.


  • Role of exposure to air pollutants in the development of type 1 diabetes before and after 5 yr of age

    by Eba H. Hathout, W. Lawrence Beeson, Fadi Nahab, Alissar Rabadi, Wendy Thomas, John W. Mace

    Objective: To assess the role of ambient air pollutants in type 1 diabetes in children. Design and methods: Prediagnosis exposure to five air pollutants was studied in two subgroups with onset of type 1 diabetes before and after 5 yr of age, and two matched subgroups of healthy children. Zip codes and dates of residence from birth to diagnosis were used to obtain geographic‐ and time‐specific air concentrations of SO2, NO2, ozone (O3), SO4, and particulate matter < 10 µm in diameter (PM10). Prediagnosis time‐adjusted pollutant exposure levels were created by summing up zip code‐specific pollution data and dividing by months of exposure from birth to diagnosis. Two‐tailed t‐test and logistic regression were used to evaluate relative effects and test data between cases and controls. Results: Prediagnosis average O3 exposure was significantly higher in children with type 1 diabetes than in healthy controls. Prediagnosis PM10 exposure was significantly higher in children diagnosed before 5 yr of age, when compared with healthy controls. SO2 exposure was significantly higher in children with later‐onset diabetes compared with those with early‐onset diabetes (EOD). NO2, SO2 and SO4 exposure was significantly lower in children diagnosed after 5 yr of age, when compared with healthy controls. O3, NO2, SO4 and PM10 levels did not significantly differ between the two diabetic subgroups. Conclusion: Increased ozone exposure may be a contributory factor to the increased incidence of type 1 diabetes. PM10 may be a specific contributory factor to the development of type 1 diabetes before 5 yr of age.